Henry Schein Inc

Henry Schein Inc(HSIC)股票分析

$86.380

-0.605 (-0.70%)收盤時

Loading chart…
最高
88.130
開盤
87.380
成交量加權均價
86.79
成交量
1.18M
市值
8.21B
最低
85.845
成交金額
102.33M
企業價值/稅息折舊攤銷前利潤(TTM)
11.71

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

AI 分析 of Henry Schein Inc (HSIC)

買進

Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.

分析師評級(16)

-11.11% 下跌空間
買進
9 買進
7 持有
0 賣出
目前: 86.38
最低
58.00
平均
76.78
最高
90.00

BTIG

2026-08-19

目標價

$110

買進

Barclays

2026-08-06

目標價

$100

增持

Mizuho

2026-08-05

目標價

$86

中性

UBS

2026-08-05

目標價

$94

中性

Barrington

2026-08-05

目標價

$104

優於大盤

估值指標

Henry Schein Inc(HSIC)目前預期本益比為 14.81,5 年平均預期本益比為 15.15。

預期本益比

合理
5 年均值 P/E
15.15
目前P/E
14.81
高估
16.64
低估
13.65

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.72
目前EV/EBITDA
11.71
高估
12.44
低估
11.00

預期股價營收比

合理
5 年均值 P/S
0.73
目前P/S
0.69
高估
0.83
低估
0.64

Alphio AI 對 HSIC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%HSIC

$82.44

情境價格

基

基準

基準 · 50%HSIC

$70.37

情境價格

悲

悲觀

悲觀 · 25%HSIC

$57.21

情境價格

持有 HSIC 的大戶

L

Lakewood Capital Management, LP

+ 持有HSIC

+6.37%

3個月報酬率

B

Burgundy Asset Management Ltd.

+ 持有HSIC

+6.08%

3個月報酬率

S

Snyder Capital Management, L.P.

+ 持有HSIC

+4.03%

3個月報酬率

S

Southpoint Capital Advisors LP

+ 持有HSIC

+3.71%

3個月報酬率

E

Everett Harris & Co.

+ 持有HSIC

+3.57%

3個月報酬率

S

Staley Capital Advisers, Inc.

+ 持有HSIC

+2.00%

3個月報酬率

事件時間軸

2026-10-08 (ET)

07:30:00

Henry Schein Appoints Emmanuel Caprais as CFO

2026-09-08 (ET)

08:30:00

Applied BioCode Signs Distribution Agreement with Henry Schein

2026-08-04 (ET)

06:30:00

Company Reports Q2 Revenue of $3.5B, Beating Expectations

06:30:00

2026 EPS Consensus at $5.34, Revenue Growth View Raised to 4.5%-5.5%

2026-07-30 (ET)

07:30:00

Henry Schein Establishes Leadership Team, Restructures Executive Management

資訊

HSIC 常見問題 —— 由 Alphio AI 解答

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易